143 related articles for article (PubMed ID: 35730051)
1. Construction Of High Loading Natural Active Substances Nanoplatform and Application in Synergistic Tumor Therapy.
Liu H; Jiapaer Z; Meng F; Wu W; Hou C; Duan M; Qin Y; Shao S; Zhang M
Int J Nanomedicine; 2022; 17():2647-2659. PubMed ID: 35730051
[TBL] [Abstract][Full Text] [Related]
2. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
3. Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy.
Tang W; Fan W; Wang Z; Zhang W; Zhou S; Liu Y; Yang Z; Shao E; Zhang G; Jacobson O; Shan L; Tian R; Cheng S; Lin L; Dai Y; Shen Z; Niu G; Xie J; Chen X
ACS Nano; 2018 Dec; 12(12):12269-12283. PubMed ID: 30418749
[TBL] [Abstract][Full Text] [Related]
4. Triple stimuli-responsive ZnO quantum dots-conjugated hollow mesoporous carbon nanoplatform for NIR-induced dual model antitumor therapy.
Feng S; Mao Y; Wang X; Zhou M; Lu H; Zhao Q; Wang S
J Colloid Interface Sci; 2020 Feb; 559():51-64. PubMed ID: 31610305
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapeutic drug-photothermal agent co-self-assembling nanoparticles for near-infrared fluorescence and photoacoustic dual-modal imaging-guided chemo-photothermal synergistic therapy.
Li Y; Liu G; Ma J; Lin J; Lin H; Su G; Chen D; Ye S; Chen X; Zhu X; Hou Z
J Control Release; 2017 Jul; 258():95-107. PubMed ID: 28501673
[TBL] [Abstract][Full Text] [Related]
6. Indocyanine green-modified hollow mesoporous Prussian blue nanoparticles loading doxorubicin for fluorescence-guided tri-modal combination therapy of cancer.
Yang R; Hou M; Gao Y; Zhang L; Xu Z; Kang Y; Xue P
Nanoscale; 2019 Mar; 11(12):5717-5731. PubMed ID: 30865744
[TBL] [Abstract][Full Text] [Related]
7. Treatment of triple negative breast cancer by near infrared light triggered mild-temperature photothermal therapy combined with oxygen-independent cytotoxic free radicals.
Li R; Hu X; Shang F; Wu W; Zhang H; Wang Y; Pan J; Shi S; Dong C
Acta Biomater; 2022 Aug; 148():218-229. PubMed ID: 35705171
[TBL] [Abstract][Full Text] [Related]
8. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment.
Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y
Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202
[TBL] [Abstract][Full Text] [Related]
9. Ofloxacin-loaded HMPB NPs for Klebsiella pneumoniae eradication in the surgical wound with the combination of PTT.
Liu T; Zhong G; Tang D; Liu X; Fan J; Zhong X; Yang Y; Tong C; Liu B; Yang X
Biotechnol Bioeng; 2022 Jul; 119(7):1949-1964. PubMed ID: 35338663
[TBL] [Abstract][Full Text] [Related]
10. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
11. An Endogenous H
Chen J; Xue F; Du W; Yu H; Yang Z; Du Q; Chen H
Nano Lett; 2022 Aug; 22(15):6156-6165. PubMed ID: 35852844
[TBL] [Abstract][Full Text] [Related]
12. Tumor targeting and penetrating biomimetic mesoporous polydopamine nanoparticles facilitate photothermal killing and autophagy blocking for synergistic tumor ablation.
Huang X; Chen L; Lin Y; Tou KI; Cai H; Jin H; Lin W; Zhang J; Cai J; Zhou H; Pi J
Acta Biomater; 2021 Dec; 136():456-472. PubMed ID: 34562660
[TBL] [Abstract][Full Text] [Related]
13. Cancer Cell-Mimicking Prussian Blue Nanoplatform for Synergistic Mild Photothermal/Chemotherapy via Heat Shock Protein Inhibition.
Wang Y; Wang J; Ye R; Jin Q; Yin F; Liu N; Wang Y; Zhang Q; Gao T; Zhao Y
ACS Appl Mater Interfaces; 2024 Apr; ():. PubMed ID: 38624164
[TBL] [Abstract][Full Text] [Related]
14. Internal cross-linked polymeric nanoparticles with dual sensitivity for combination therapy of muscle-invasive bladder cancer.
Zhu G; Wang K; Qin H; Zhao X; Chen W; Xu L; Cao W; Guo H
J Nanobiotechnology; 2020 Sep; 18(1):124. PubMed ID: 32887622
[TBL] [Abstract][Full Text] [Related]
15. "Navigate-dock-activate" anti-tumor strategy: Tumor micromilieu charge-switchable, hierarchically activated nanoplatform with ultrarapid tumor-tropic accumulation for trackable photothermal/chemotherapy.
Cherukula K; Uthaman S; Park IK
Theranostics; 2019; 9(9):2505-2525. PubMed ID: 31131050
[TBL] [Abstract][Full Text] [Related]
16. PPy@MIL-100 Nanoparticles as a pH- and Near-IR-Irradiation-Responsive Drug Carrier for Simultaneous Photothermal Therapy and Chemotherapy of Cancer Cells.
Zhu YD; Chen SP; Zhao H; Yang Y; Chen XQ; Sun J; Fan HS; Zhang XD
ACS Appl Mater Interfaces; 2016 Dec; 8(50):34209-34217. PubMed ID: 27998104
[TBL] [Abstract][Full Text] [Related]
17. Engineering of a dual-modal phototherapeutic nanoplatform for single NIR laser-triggered tumor therapy.
Zhang M; Qin X; Xu W; Wang Y; Song Y; Garg S; Luan Y
J Colloid Interface Sci; 2021 Jul; 594():493-501. PubMed ID: 33774405
[TBL] [Abstract][Full Text] [Related]
18. Programmed near-infrared light-responsive drug delivery system for combined magnetic tumor-targeting magnetic resonance imaging and chemo-phototherapy.
Feng Q; Zhang Y; Zhang W; Hao Y; Wang Y; Zhang H; Hou L; Zhang Z
Acta Biomater; 2017 Feb; 49():402-413. PubMed ID: 27890732
[TBL] [Abstract][Full Text] [Related]
19. Albumin-bioinspired iridium oxide nanoplatform with high photothermal conversion efficiency for synergistic chemo-photothermal of osteosarcoma.
Gu W; Zhang T; Gao J; Wang Y; Li D; Zhao Z; Jiang B; Dong Z; Liu H
Drug Deliv; 2019 Dec; 26(1):918-927. PubMed ID: 31526064
[TBL] [Abstract][Full Text] [Related]
20. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
